Cover Image
市場調查報告書

輸卵管癌:全球臨床實驗檢討

Fallopian Tube Cancer Global Clinical Trials Review, H1, 2016

出版商 GlobalData 商品編碼 226859
出版日期 內容資訊 英文 698 Pages
訂單完成後即時交付
價格
Back to Top
輸卵管癌:全球臨床實驗檢討 Fallopian Tube Cancer Global Clinical Trials Review, H1, 2016
出版日期: 2016年05月19日 內容資訊: 英文 698 Pages
簡介

目錄

目錄

  • 表格一覽
  • 圖表一覽
  • 簡介
  • 輸卵管癌
  • 報告指南
  • 臨床實驗 各地區
  • 臨床實驗 各國
  • 對臨床實驗有所貢獻的前五國 - 亞太地區
  • 對臨床實驗有所貢獻的前五國 - 歐洲
  • 對臨床實驗有所貢獻的前幾名國家 - 北美
  • 對臨床實驗有所貢獻的前幾名國家 - 中東及非洲
  • 對臨床實驗有所貢獻的前五國 - 中南美
  • 臨床實驗 ; 金磚四國 各國
  • 臨床實驗 ; G7 各國
  • 臨床實驗 - G7 各國 各臨床實驗狀態
  • 臨床實驗 ; E7 各國
  • 臨床實驗 - E7 各國 各臨床實驗狀態
  • 臨床實驗 各階段
  • 進行中的臨床實驗 各階段
  • 臨床實驗 各臨床實驗狀態
  • 未完成的臨床實驗; 輸卵管癌
  • 每段時期的實驗人數
  • 有力的贊助商
  • 前幾名參與企業 - 輸卵管癌 治療藥物的臨床實驗
  • 潛力治療藥物比較
  • 臨床實驗簡介
  • 臨床實驗概要; 前幾名企業
  • Amgen Inc.
  • 臨床實驗概要; Amgen Inc.
  • GlaxoSmithKline plc
  • 臨床實驗概要; GlaxoSmithKline plc
  • Eli Lilly and Company
  • 臨床實驗概要; Eli Lilly and Company
  • Marshall Edwards, Inc.
  • 臨床實驗概要; Marshall Edwards, Inc.
  • Precision Therapeutics, Inc.
  • 臨床實驗概要; Precision Therapeutics, Inc.
  • Novartis AG
  • 臨床實驗概要; Novartis AG
  • 武田藥品工業
  • 臨床實驗概要; 武田藥品工業
  • Merck & Co., Inc.
  • 臨床實驗概要; Merck & Co., Inc.
  • Genentech, Inc.
  • 臨床實驗概要; Genentech, Inc.
  • Abbott Laboratories
  • 臨床實驗概要; Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • 臨床實驗概要; F. Hoffmann-La Roche Ltd.
  • Merrimack Pharmaceuticals, Inc.
  • 臨床實驗概要; Merrimack Pharmaceuticals, Inc.
  • RECEPTA Biopharma S.A.
  • 臨床實驗概要; RECEPTA Biopharma S.A.
  • ARCAGY - GINECO
  • 臨床實驗概要; ARCAGY - GINECO
  • AltaRex Corp
  • 臨床實驗概要; AltaRex Corp
  • Southeastern Gynecologic Oncology LLC
  • 臨床實驗概要; Southeastern Gynecologic Oncology LLC
  • 第一三共
  • 臨床實驗概要; 第一三共
  • Oasmia Pharmaceutical AB
  • 臨床實驗概要; Oasmia Pharmaceutical AB
  • TopoTarget A/S
  • 臨床實驗概要; TopoTarget A/S
  • AstraZeneca PLC
  • 臨床實驗概要; AstraZeneca PLC
  • 臨床實驗概要; 最高級大學 / 研究機關 / 醫院
  • Gynecologic Oncology Group
  • 臨床實驗概要; Gynecologic Oncology Group
  • Memorial Sloan Kettering Cancer Center
  • 臨床實驗概要; Memorial Sloan Kettering Cancer Center
  • Dana-Farber Cancer Institute
  • 臨床實驗概要; Dana-Farber Cancer Institute
  • The University of Texas M. D. Anderson Cancer Center
  • 臨床實驗概要; The University of Texas M. D. Anderson Cancer Center
  • Masonic Cancer Center
  • 臨床實驗概要; Masonic Cancer Center
  • Princess Margaret Hospital
  • 臨床實驗概要; Princess Margaret Hospital
  • Beth Israel Deaconess Medical Center
  • 臨床實驗概要; Beth Israel Deaconess Medical Center
  • Southwest Oncology Group
  • 臨床實驗概要; Southwest Oncology Group
  • Case Comprehensive Cancer Center
  • 臨床實驗概要; Case Comprehensive Cancer Center
  • Abramson Cancer Center
  • 臨床實驗概要; Abramson Cancer Center
  • European Organization for Research and Therapeutics of Cancer
  • 臨床實驗概要; European Organization for Research and Therapeutics of Cancer
  • H. Lee Moffitt Cancer Center & Research Institute
  • 臨床實驗概要; H. Lee Moffitt Cancer Center & Research Institute
  • Albert Einstein College of Medicine of Yeshiva University
  • 臨床實驗概要; Albert Einstein College of Medicine of Yeshiva University
  • The Ohio State University
  • 臨床實驗概要; The Ohio State University
  • Massachusetts General Hospital
  • 臨床實驗概要; Massachusetts General Hospital
  • University of Pittsburgh
  • 臨床實驗概要; University of Pittsburgh
  • New York University School of Medicine
  • 臨床實驗概要; New York University School of Medicine
  • Fred Hutchinson Cancer Research Center
  • 臨床實驗概要; Fred Hutchinson Cancer Research Center
  • Fox Chase Cancer Center
  • 臨床實驗概要; Fox Chase Cancer Center
  • University College London Hospital
  • 臨床實驗概要; University College London Hospital
  • 5件重要臨床簡介

附錄

  • 簡稱
  • 定義
  • 調查方法
  • 二級研究
  • 關於GlobalData
  • 諮詢方式
  • 免責聲明
  • 資訊來源

表格一覽

  • 輸卵管癌 全球治療藥物市場, 臨床實驗 各地區
  • 輸卵管癌 全球治療藥物市場, 臨床實驗 各國排名
  • 輸卵管癌 全球治療藥物市場, 進行中的臨床實驗 各國排名
  • 輸卵管癌 治療藥物的臨床實驗, 亞太地區, 前五國
  • 輸卵管癌 治療藥物的臨床實驗, 歐洲, 前五國
  • 輸卵管癌 治療藥物的臨床實驗, 北美, 前幾名國家
  • 輸卵管癌 治療藥物的臨床實驗, 中東及非洲, 前幾名國家
  • 輸卵管癌 治療藥物的臨床實驗, 中南美, 前五國
  • 輸卵管癌 治療藥物的臨床實驗, 金磚四國 各國
  • 輸卵管癌 治療藥物的臨床實驗, G7 各國
  • 輸卵管癌 治療藥物市場, G7 各國, 臨床實驗 各臨床實驗狀態
  • 輸卵管癌 治療藥物的臨床實驗, E7 各國
  • 輸卵管癌 治療藥物市場, E7 各國, 臨床實驗 各臨床實驗狀態
  • 輸卵管癌 全球治療藥物市場, 臨床實驗 各階段
  • 輸卵管癌 全球治療藥物市場, 進行中的臨床實驗 各階段
  • 輸卵管癌 全球治療藥物市場, 臨床實驗 各臨床實驗狀態
  • 輸卵管癌 全球治療藥物市場, 一時中止的臨床實驗
  • 輸卵管癌 全球治療藥物市場, 終止的臨床實驗
  • 輸卵管癌 全球治療藥物臨床實驗, 平均登錄對象人數趨勢
  • 輸卵管癌 全球治療藥物臨床實驗, 主要的贊助商
  • 輸卵管癌 全球治療藥物臨床實驗, 前幾名企業 各階段
  • 輸卵管癌 全球治療藥物臨床實驗, 臨床實驗 ; 潛力治療藥物
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Amgen Inc. 
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; GlaxoSmithKline plc
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Eli Lilly and Company
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Marshall Edwards, Inc. 
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Precision Therapeutics, Inc. 
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Novartis AG
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; 武田藥品工業
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Merck & Co., Inc. 
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Genentech, Inc. 
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Abbott Laboratories
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; F. Hoffmann-La Roche Ltd. 
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Merrimack Pharmaceuticals, Inc. 
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; RECEPTA Biopharma S.A. 
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; ARCAGY - GINECO
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; AltaRex Corp
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Southeastern Gynecologic Oncology LLC
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; 第一三共
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Oasmia Pharmaceutical AB
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; TopoTarget A/S
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; AstraZeneca PLC
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Gynecologic Oncology Group
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Memorial Sloan Kettering Cancer Center
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Dana-Farber Cancer Institute
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; The University of Texas M. D. Anderson Cancer Center
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Masonic Cancer Center
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Princess Margaret Hospital
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Beth Israel Deaconess Medical Center
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Southwest Oncology Group
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Case Comprehensive Cancer Center
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Abramson Cancer Center
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; European Organization for Research and Therapeutics of Cancer
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; H. Lee Moffitt Cancer Center & Research Institute
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Albert Einstein College of Medicine of Yeshiva University
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; The Ohio State University
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Massachusetts General Hospital
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; University of Pittsburgh
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; New York University School of Medicine
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Fred Hutchinson Cancer Research Center
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Fox Chase Cancer Center
  • 輸卵管癌 全球治療藥物臨床實驗市場, 臨床實驗 ; University College London Hospital

圖表一覽

  • 輸卵管癌 全球治療藥物市場, 臨床實驗 各地區 (%)
  • 輸卵管癌 全球治療藥物市場, 臨床實驗 各國排名
  • 輸卵管癌 全球治療藥物市場, 進行中的臨床實驗 各國排名
  • 輸卵管癌 治療藥物的臨床實驗, 亞太地區, 前五國 (%)
  • 輸卵管癌 治療藥物的臨床實驗, 歐洲, 前五國 (%)
  • 輸卵管癌 治療藥物的臨床實驗, 北美, 前幾名國家 (%)
  • 輸卵管癌 治療藥物的臨床實驗, 中東及非洲, 前幾名國家 (%)
  • 輸卵管癌 治療藥物的臨床實驗, 中南美, 前五國 (%)
  • 輸卵管癌 治療藥物的臨床實驗, 金磚四國 各國 (%)
  • 輸卵管癌 治療藥物的臨床實驗, G7 各國 (%)
  • 輸卵管癌 治療藥物市場, G7 各國, 臨床實驗 各臨床實驗狀態
  • 輸卵管癌 治療藥物的臨床實驗, E7 各國 (%)
  • 輸卵管癌 治療藥物市場, E7 各國, 臨床實驗 各臨床實驗狀態
  • 輸卵管癌 全球治療藥物市場, 臨床實驗 各階段 (%)
  • 輸卵管癌 全球治療藥物市場, 進行中的臨床實驗 各階段
  • 輸卵管癌 全球治療藥物市場, 臨床實驗 各臨床實驗狀態
  • 輸卵管癌 全球治療藥物臨床實驗, 平均登錄對象人數趨勢
  • 輸卵管癌 全球治療藥物臨床實驗, 主要的贊助商
  • 輸卵管癌 全球治療藥物臨床實驗, 前幾名企業 各階段
  • 輸卵管癌 全球治療藥物臨床實驗, 臨床實驗 ; 潛力治療藥物
  • GlobalData 調查方法

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3407CTIDB

GlobalData's clinical trial report, "Fallopian Tube Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Fallopian Tube Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Fallopian Tube Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Fallopian Tube Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Fallopian Tube Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Fallopian Tube Cancer Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Fallopian Tube Cancer Therapeutics, Global, Clinical Trials by Region, 2016*
  • Fallopian Tube Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Fallopian Tube Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Fallopian Tube Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016*
  • Fallopian Tube Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2016*
  • Fallopian Tube Cancer Therapeutics Clinical Trials, North America, Top Countries, 2016*
  • Fallopian Tube Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016*
  • Fallopian Tube Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016*
  • Proportion of Fallopian Tube Cancer to Oncology Clinical Trials, G7 Countries (%), 2016*
  • Fallopian Tube Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Fallopian Tube Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Fallopian Tube Cancer to Oncology Clinical Trials, E7 Countries (%), 2016*
  • Fallopian Tube Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Fallopian Tube Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Fallopian Tube Cancer Therapeutics, Global, Clinical Trials by Phase, 2016*
  • Fallopian Tube Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2016*
  • Fallopian Tube Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Fallopian Tube Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Fallopian Tube Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Fallopian Tube Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*
  • Fallopian Tube Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Fallopian Tube Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Fallopian Tube Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*

List of Figures

  • Fallopian Tube Cancer Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Fallopian Tube Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Fallopian Tube Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Fallopian Tube Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016*
  • Fallopian Tube Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016*
  • Fallopian Tube Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2016*
  • Fallopian Tube Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016*
  • Fallopian Tube Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016*
  • Proportion of Fallopian Tube Cancer to Oncology Clinical Trials, G7 Countries (%), 2016*
  • Fallopian Tube Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Fallopian Tube Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Fallopian Tube Cancer to Oncology Clinical Trials, E7 Countries (%), 2016*
  • Fallopian Tube Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Fallopian Tube Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Fallopian Tube Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2016*
  • Fallopian Tube Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2016*
  • Fallopian Tube Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Fallopian Tube Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Fallopian Tube Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Fallopian Tube Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*
  • Fallopian Tube Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Fallopian Tube Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Fallopian Tube Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*
  • GlobalData Methodology
Back to Top